Intraarticular hemorrhage due to bevacizumab in a patient with metastatic colorectal cancer: a case report
<p>Abstract</p> <p>Introduction</p> <p>Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It is widely used in the treatment of metastatic colorectal cancer. It has some specific side effects including severe bleeding, wound healing problems, gastrointestinal perforatio...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2012-07-01
|
| Ráidu: | Journal of Medical Case Reports |
| Fáttát: | |
| Liŋkkat: | http://www.jmedicalcasereports.com/content/6/1/188 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|